The fair value estimate for Integral Diagnostics is 29% higher than the analyst price target. Using a Discounted Cash Flow model, we project future cash flows to estimate intrinsic value. The DCF model considers growth rates in two stages over a period of ten years.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing